Seòmar agus comataidhean

The Scottish Government has convened a Short Life Working Group (SLWG) to look at Prescription Medicine Dependence and Withdrawal. This SLWG is considering the findings of the Public Health England Prescribed Medicines Review in a Scottish context. We expect to report on the SLWG findings in the autumn and the recommendations will centred around the actions required to assists patients who are prescribed drugs known to have dependence effects, including opioid pain medication. Scottish Government is in the process of reviewing its “Quality Prescribing for Chronic Pain – A Guide for Improvement” – this stresses the need to proactively review patients who have been prescribed opioids.

I refer the member to the answer to question S5W-30134 on 20 July 2020. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx '.

The overall budget for Public Dental Services for 2020-21 will be equivalent to 2019-20.

On 10 July, the Scottish Government published guidance for close contact services which applies to hairdressers and other personal retail services.

This guidance is based on a risk assessment process which business owners should use to identify which treatments and activities can be offered safely. This includes a comprehensive checklist to be used to implement safe working practices.

I refer the member to the answer to question S5W-30128 on 7 July 2020. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx .

I refer the member to the answer to question S5W-30128 on 7 July 2020. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx .

I refer the member to the answer to question S5W-30128 on 7 July 2020. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx .

The information is not held centrally. Please refer to answer to question S5W-29384 on 16 July 2020 for further information about data on hospital admissions from care homes. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx

The Covid-19 Clinical Guidance Cell, which was established by the Chief Medical Officer to rapidly develop and revise guidance on clinical management of COVID-19 for the NHS, has produced guidance on prevention of venous thromboembolism in hospitalised patients with COVID-19-related disease.

This guidance has been developed in partnership with Health Improvement Scotland and SIGN, based on review of available evidence. It is currently at the peer review stage and is going to be published on the SIGN website soon.

As part of the response to the COVID-19 pandemic, the Chief Scientist Office (CSO) launched the Rapid Research in COVID-19 programme on March 25th 2020. Following independent expert review, the list of funded applications was published on April 28th 2020. No applications specifically addressing links between COVID-19 and DVT were received. A number of projects were funded on COVID-19 related inflammation, hypertension and cardiovascular injury with potential pathophysiological relevance to DVT. Links to the lay summaries of these studies on the CSO website are provided below.

https://www.cso.scot.nhs.uk/wp-content/uploads/COVEDI2010.pdf

https://www.cso.scot.nhs.uk/wp-content/uploads/COVGLA2004.pdf

https://www.cso.scot.nhs.uk/wp-content/uploads/COVGLA2005.pdf

The full list of funded projects is available from the CSO website

https://www.cso.scot.nhs.uk/rapid-research-in-covid-19-programme/

The phased resumption of visiting and communal activity in care homes was referred to in ‘Scotland’s route map through and out of the crisis’. On the 25 th June, the Scottish Government published the Coronavirus (COVID-19): adult care home visiting guidance. This guidance sets out a new 4 stage pathway on how care home visiting restrictions are to be gradually lifted.

Effective on the 3 rd July, care homes which have been COVID free for 28 days will, subject to the agreement of the local Health Protection and Care Home Clinical and Care Professional Oversight teams, be able to move to stage 2 of the pathway which allows for outdoor visits to care home residents by a designated visitor of their choice.

Stages 3 will subsequently allow indoor visits by the designated visitor and greater freedom for outdoor visits and communal activity, whilst stage 4 will see the introduction of indoor visits by visitors Progression along the pathway to stages 3 and 4 will be dependent on whether the scientific evidence indicates that is it safe to do so.

The phased resumption of visiting and communal activity in care homes was referred to in ‘Scotland’s route map through and out of the crisis’.On the 25 th June, the Scottish Government published the Coronavirus (COVID-19): adult care home visiting guidance. This guidance sets out a new 4 stage pathway on how care home visiting restrictions are to be gradually lifted.